ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,978Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 121

$492K Total Retail Price of All Prescriptions

Rank: 33 out of 121

333 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 333 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

31% of this provider’s 333 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 8,081 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $171 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 489 350 1 13
HYDROCODONE-ACETAMINOPHEN 470 329 S3 2 4
METHOTREXATE 405 237 3 1
OMEPRAZOLE 382 281 4 8
SIMVASTATIN 349 295 5 16
METOPROLOL TARTRATE 291 224 6 28
FUROSEMIDE 286 250 7 24
PREDNISONE 241 124 8 2
LISINOPRIL 238 197 9 19
TRAMADOL HCL 224 171 10 5
MELOXICAM 204 122 11 9
ZOLPIDEM TARTRATE 201 172 12 18
AMLODIPINE BESYLATE 197 179 13 29
METFORMIN HCL 190 127 14 34
LOSARTAN POTASSIUM 170 143 15 43
GABAPENTIN 155 108 16 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 149 118 17 54
CELEBREX 144 143 18 17
NEXIUM 142 92 19 84
TRAZODONE HCL 122 56 20 39
LIDODERM 117 100 21 69
TRIAMTERENE-HCTZ 115 96 22 73
WARFARIN SODIUM 106 84 23 53
SERTRALINE HCL 103 54 24 56
OXYBUTYNIN CHLORIDE 102 59 25 74
METOPROLOL SUCCINATE 102 94 25 63
HYDROCHLOROTHIAZIDE 101 73 27 50
LOSARTAN-HYDROCHLOROTHIAZIDE 99 94 28 97
POTASSIUM CHLORIDE 97 62 29 42
CLOPIDOGREL 96 69 30 62
RANITIDINE HCL 88 61 31 68
FENTANYL 87 64 S2 32 26
ALENDRONATE SODIUM 83 83 33 11
HYDROXYCHLOROQUINE SULFATE 81 25 34 3
DONEPEZIL HCL 77 77 35 67
CARVEDILOL 73 56 36 46
ACETAMINOPHEN-CODEINE 72 59 S3 37 27
SPIRONOLACTONE 71 60 38 63
CLONIDINE HCL 70 51 39 77
POLYETHYLENE GLYCOL 3350 68 55 40 82
GLIMEPIRIDE 67 41 41 107
MECLIZINE HCL 65 56 42 110
CYCLOBENZAPRINE HCL 65 34 R 42 14
IBUPROFEN 65 32 42 48
LOVASTATIN 64 47 45 79
AMITRIPTYLINE HCL 63 33 R 46 40
PAROXETINE HCL 58 34 47 115
CLOTRIMAZOLE-BETAMETHASONE 57 45 48 119
NABUMETONE 55 52 49 44
PROAIR HFA 55 30 49 65
CEPHALEXIN 55 33 49 82
PLAVIX 55 44 49 92
JANUVIA 51 39 53 126
LYRICA 50 27 54 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 19, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.